Gene Expression of the EGF System—a Prognostic Model in Non–Small Cell Lung Cancer Patients Without Activating EGFR Mutations
OBJECTIVES: Contradicting results have been demonstrated for the expression of the epidermal growth factor receptor (EGFR) as a prognostic marker in non–small cell lung cancer (NSCLC). The complexity of the EGF system with four interacting receptors and more than a dozen activating ligands is a like...
Main Authors: | Birgitte Sandfeld-Paulsen, Birgitte Holst Folkersen, Torben Riis Rasmussen, Peter Meldgaard, Boe S. Sorensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-08-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523316300547 |
Similar Items
-
Neurofilament Light Chain as A Biomarker for Brain Metastases
by: Anne Winther-Larsen, et al.
Published: (2020-10-01) -
Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis
by: Anne Winther-Larsen, et al.
Published: (2021-01-01) -
Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients
by: Anne Winther-Larsen, et al.
Published: (2022-01-01) -
Pretreatment Albumin-to-Alkaline Phosphatase Ratio Is a Prognostic Marker in Lung Cancer Patients: A Registry-Based Study of 7077 Lung Cancer Patients
by: Birgitte Sandfeld-Paulsen, et al.
Published: (2021-12-01) -
Introduction of cryobiopsies in the diagnostics of interstitial lung diseases – experiences in a referral center
by: Sissel Kronborg-White, et al.
Published: (2017-01-01)